2025 annual financial data

Cumberland Pharmaceuticals 2025 Net margin

Cumberland Pharmaceuticals 2025 net margin with verified reported values.

Direct answer

Net margin was -6.37%.

Operating income was -2,791,993 USD and net income was -2,836,128 USD.
Operating cash flow was 4,932,522 USD.

Get free Cumberland Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
44,521,431 USD
Operating income
-2,791,993 USD
Net income
-2,836,128 USD
Operating cash flow
4,932,522 USD